AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20568520 — intervention group
Group type: COMPARATOR
Intervention: Mesenchymal stem cells (MSCs) therapy
Number of subjects: 0
Study 18263901 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care (feedback, manual, and up to three counselling sessions)
Number of subjects: 408
Study 18263901 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed care (four sessions)
Number of subjects: 408
Study 18263901 — intervention group
Group type: COMPARATOR
Intervention: Stepped care
Number of subjects: 408
Study 16873343 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone 2 mg
Number of subjects: 41
Study 16873343 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone 1 mg
Number of subjects: 41
Study 16873343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 41
Study 16873343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 12903037 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 short tandem repeat (STR) loci on chromosome 7p14-15
Number of subjects: 100
Study 12903037 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 short tandem repeat (STR) loci on chromosome 12q13
Number of subjects: 100
Study 10799631 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mL of undiluted albuterol nebulized for 20 inhalations every 20 minutes for a total of 3 treatments.
Number of subjects: 50
Study 10799631 — intervention group
Group type: COMPARATOR
Intervention: Albuterol diluted (0.5 mL) and nebulized in normal saline (3 mL) every 20 minutes for a total of 3 treatments.
Number of subjects: 50
Study 10799631 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (undiluted albuterol)
Number of subjects: 50
Study 10799631 — intervention group
Group type: COMPARATOR
Intervention: Control group (diluted albuterol)
Number of subjects: 50
Study 8967585 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and fentanyl
Number of subjects: 60
Study 8967585 — intervention group
Group type: COMPARATOR
Intervention: Standard isoflurane anesthesia
Number of subjects: 60
Study 8967585 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane using a low-flow system (fresh gas flow 2 l/min)
Number of subjects: 60
Study 1640029 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin via the endotracheal tube
Number of subjects: 0
Study 1640029 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined approach (SDD) of oropharyngeal, gastrointestinal and parenteral use of certain antibiotics
Number of subjects: 0
Study 6150321 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 38
Study 30991815 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (intraoperative plus 5 days)
Number of subjects: 200
Study 30991815 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (intraoperative plus 5 days)
Number of subjects: 200
Study 29974433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT) 100 μg (group A)
Number of subjects: 66
Study 29974433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT) 200 μg (group B)
Number of subjects: 66
Study 29974433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT)
Number of subjects: 66
Study 26340704 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Detemir
Number of subjects: 56
Study 24271646 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicapone (50 mg oral dose) in patients with moderate liver impairment
Number of subjects: 16
Study 24271646 — intervention group
Group type: COMPARATOR
Intervention: Opicapone (50 mg oral dose) in healthy subjects (control)
Number of subjects: 16
Study 23022943 — intervention group
Group type: EXPERIMENTAL
Intervention: Miracle Fruit™ supplement
Number of subjects: 8
Study 23022943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 19460960 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodized salt (150-250 microg/d for adults)
Number of subjects: 2000000000
Study 19460960 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal salt iodization
Number of subjects: 2000000000
Study 19460960 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation during pregnancy
Number of subjects: 2000000000
Study 19460960 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine disinfectants
Number of subjects: 2000000000
Study 19460960 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of iodized salt
Number of subjects: 2000000000
Study 18070735 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 375
Study 18070735 — intervention group
Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy
Number of subjects: 375
Study 15674406 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day)
Number of subjects: 50
Study 15674406 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone (25 mg/day)
Number of subjects: 50
Study 12375237 — intervention group
Group type: EXPERIMENTAL
Intervention: Cruciate-retaining (CR) total knee arthroplasty (NexGen, Zimmer, Warsaw, IN)
Number of subjects: 40
Study 12375237 — intervention group
Group type: COMPARATOR
Intervention: Posterior-stabilized (PS) total knee arthroplasty (Legacy PS, Zimmer, Warsaw, IN)
Number of subjects: 40
Study 10545689 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS administered by neurologists
Number of subjects: 31
Study 10545689 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS administered by research nurses
Number of subjects: 31
Study 10545689 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS administered by research nurses and neurologists
Number of subjects: 31
Study 8779650 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplementation in cases of initially insufficient vitamin supply
Number of subjects: 0
Study 8779650 — intervention group
Group type: COMPARATOR
Intervention: Supplemental vitamin intake in physiological dosages in addition to a vitamin-sufficient diet
Number of subjects: 0
Study 2225500 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency emphasis commercial aid
Number of subjects: 0
Study 2225500 — intervention group
Group type: COMPARATOR
Intervention: Standard NHS contracted hearing aid
Number of subjects: 0
Study 376210 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine three times a day with a diuretic
Number of subjects: 18
Study 376210 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine twice a day with a diuretic
Number of subjects: 18
Study 376210 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study 30739176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectoine lozenges
Number of subjects: 90
Study 30739176 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid lozenges
Number of subjects: 90
Study 30739176 — intervention group
Group type: COMPARATOR
Intervention: Saline gargle
Number of subjects: 90
Study 28619989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alteplase (0.6 mg/kg)
Number of subjects: 752
Study 28619989 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose alteplase (0.9 mg/kg)
Number of subjects: 752
Study 28619989 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (both doses)
Number of subjects: 752
Study 25872171 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus lornoxicam
Number of subjects: 334
Study 25872171 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 334
Study 24013940 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-jump exercise
Number of subjects: 0
Study 24013940 — intervention group
Group type: COMPARATOR
Intervention: Level-jump exercise
Number of subjects: 0
Study 24013940 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 0
Study 21377715 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (48% fat, 49 g)
Number of subjects: 66
Study 21377715 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (15% fat, 3 g)
Number of subjects: 66
Study 21377715 — intervention group
Group type: EXPERIMENTAL
Intervention: High-trans fatty acid meal (5.2 g trans fat)
Number of subjects: 66
Study 21377715 — intervention group
Group type: COMPARATOR
Intervention: Nontrans fatty acid meal (<0.3 g trans fat)
Number of subjects: 66
Study 19424036 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose cyclosporine A (CsA; 150-300 ng/mL for 3 months then 100-200 ng/mL)
Number of subjects: 1645
Study 19424036 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (CsA; 50-100 ng/mL)
Number of subjects: 1645
Study 19424036 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (Tac; 3-7 ng/mL)
Number of subjects: 1645
Study 19424036 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (SRL; 4-8 ng/mL)
Number of subjects: 1645
Study 17896302 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PALs)
Number of subjects: 469
Study 17896302 — intervention group
Group type: COMPARATOR
Intervention: Single vision lenses (SVLs)
Number of subjects: 469
Study 17896302 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental myopia
Number of subjects: 469
Study 15098129 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cool-down (AC)
Number of subjects: 10
Study 15098129 — intervention group
Group type: COMPARATOR
Intervention: Passive cool-down (PC)
Number of subjects: 10
Study 11817530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 4 g/l
Number of subjects: 33
Study 11817530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 8 g/l
Number of subjects: 33
Study 11817530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mannitol)
Number of subjects: 33
Study 9817093 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound
Number of subjects: 50
Study 9817093 — intervention group
Group type: COMPARATOR
Intervention: Venography (gold standard)
Number of subjects: 50
Study 7624494 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine treatment
Number of subjects: 21
Study 2677092 — intervention group
Group type: EXPERIMENTAL
Intervention: HMW-GOID
Number of subjects: 60
Study 2677092 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized orchard grass-pollen extract
Number of subjects: 60
Study 2677092 — intervention group
Group type: EXPERIMENTAL
Intervention: GOID
Number of subjects: 60
Study 2677092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 357456 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (12.5, 25, or 50 mg)
Number of subjects: 1295
Study 357456 — intervention group
Group type: EXPERIMENTAL
Intervention: Methapyrilene (36, 72, or 144 mg)
Number of subjects: 1295
Study 357456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1295
Study 31309737 — intervention group
Group type: EXPERIMENTAL
Intervention: Core outcome set for systemic sclerosis (SSc) trials
Number of subjects: 4193
Study 31309737 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISS measures
Number of subjects: 4193
Study 31309737 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQoL) and function
Number of subjects: 4193
Study 31309737 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin outcomes
Number of subjects: 4193
Study 31309737 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary outcomes
Number of subjects: 4193
Study 30611592 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐cost self‐made arthroscopic camera (LAC)
Number of subjects: 153
Study 30611592 — intervention group
Group type: COMPARATOR
Intervention: Commercial arthroscopic camera (CAC)
Number of subjects: 153
Study 29182634 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct provision of HIV self-tests
Number of subjects: 960
Study 29182634 — intervention group
Group type: COMPARATOR
Intervention: Standard of care HIV testing
Number of subjects: 960
Study 25523888 — intervention group
Group type: EXPERIMENTAL
Intervention: FDA scoring system for fentanyl TDS adhesion
Number of subjects: 30
Study 23619951 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component higher-functioning autism anti-stigma program
Number of subjects: 395
Study 23619951 — intervention group
Group type: COMPARATOR
Intervention: No-intervention peer condition
Number of subjects: 395
Study 23619951 — intervention group
Group type: COMPARATOR
Intervention: No-intervention non-peer condition
Number of subjects: 395
Study 21818354 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS over the DLPFC
Number of subjects: 24
Study 21818354 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 24
Study 19781403 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 4954
Study 16936159 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg t.i.d.
Number of subjects: 219
Study 16936159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 14769097 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical expectancy model
Number of subjects: 0
Study 10966893 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 295
Study 8828671 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% O2
Number of subjects: 11
Study 8828671 — intervention group
Group type: EXPERIMENTAL
Intervention: 21% O2
Number of subjects: 11
Study 8828671 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2
Number of subjects: 11
Study 1916978 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar anaesthesia
Number of subjects: 142
Study 1916978 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anaesthesia
Number of subjects: 142
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled isoproterenol alone
Number of subjects: 102
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol plus intravenous aminophylline
Number of subjects: 102
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol plus a single oral dose of an elixir of theophylline
Number of subjects: 102
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable sympathomimetic agent (given if treatment beyond 60 minutes was required)
Number of subjects: 102
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of obstruction at presentation
Number of subjects: 102
Study 7058839 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial 1‐second forced expiratory volumes less than 30 percent of predicted
Number of subjects: 102
Study 30220556 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral VIM DBS
Number of subjects: 119
Study 30220556 — intervention group
Group type: COMPARATOR
Intervention: Staged bilateral DBS
Number of subjects: 119
Study 27618471 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast loading protocol (3 bench-throws with 30% load of 1RM, conditioning set of 5 bench-throws with 60% load of 1RM, followed by 2 sets of 3 bench-throws with 30% load of 1RM)
Number of subjects: 11
Study 27618471 — intervention group
Group type: COMPARATOR
Intervention: Control protocol (3 sets of 3 bench-throws with 30% load of 1RM)
Number of subjects: 11
Study 25200037 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg orally 1 hour prior to induction of anesthesia
Number of subjects: 60
Study 25200037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25074944 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Noninvasive Ventilation (HI-NIV)
Number of subjects: 14
Study 25074944 — intervention group
Group type: COMPARATOR
Intervention: Target Tidal Volume Noninvasive Ventilation (target V(T) NIV)
Number of subjects: 14
Study 22459631 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm medium prewarmed to 37°C
Number of subjects: 200
Study 22459631 — intervention group
Group type: COMPARATOR
Intervention: Cold medium at room temperature
Number of subjects: 200
Study 20923841 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife care
Number of subjects: 1708
Study 20923841 — intervention group
Group type: EXPERIMENTAL
Intervention: GP parallel testing
Number of subjects: 1708
Study 20923841 — intervention group
Group type: EXPERIMENTAL
Intervention: GP sequential testing
Number of subjects: 1708
Study 19016089 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 0
Study 15934028 — intervention group
Group type: EXPERIMENTAL
Intervention: WS®1490 (kava-kava extract)
Number of subjects: 0
Study 15934028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12044531 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM/IFN combination therapy (IFN at 5MU t.i.w. + LAM at 100mg/day)
Number of subjects: 50
Study 12044531 — intervention group
Group type: COMPARATOR
Intervention: LAM monotherapy (LAM at 100mg/day)
Number of subjects: 50
Study 10527090 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic exercise of the quadriceps muscle three times weekly over 8 weeks
Number of subjects: 113
Study 10527090 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention (4 discussions and lectures led by health care professionals)
Number of subjects: 113
Study 8821072 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0
Study 8821072 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine-agonists
Number of subjects: 0
Study 2626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg for children younger than 12 years and 12 mg for adults every 12 hours for 3 days) in addition to standard antibacterial chemotherapy (ampicillin and chloramphenicol)
Number of subjects: 429
Study 2626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 429
Study 2626285 — intervention group
Group type: COMPARATOR
Intervention: Control group (antibacterial chemotherapy alone)
Number of subjects: 429
Study 2626285 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone and Control group
Number of subjects: 429
Study 1105112 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin (80 mg intramuscular injection at the time of anaesthetic premedication)
Number of subjects: 80
Study 1105112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 1105112 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 80
Study 30601999 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (500 IU/day)
Number of subjects: 223
Study 30601999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 29319061 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol gum plus oral health education
Number of subjects: 174
Study 29319061 — intervention group
Group type: COMPARATOR
Intervention: Oral health education alone
Number of subjects: 174
Study 26261190 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based physical exercise at work during working hours
Number of subjects: 200
Study 26261190 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise at home during leisure time
Number of subjects: 200
Study 22942376 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxy assent process in a randomised controlled trial of influenza vaccination
Number of subjects: 968
Study 21442807 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Shiqizhui (Extra) in the premenstrual period (group A, n = 20)
Number of subjects: 80
Study 21442807 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Shiqizhui (Extra) when pain occurs (group B, n = 20)
Number of subjects: 80
Study 21442807 — intervention group
Group type: COMPARATOR
Intervention: Blank group (group C, n = 40)
Number of subjects: 80
Study 19674471 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 140
Study 19674471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 21998085 — intervention group
Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure
Number of subjects: 63
Study 21998085 — intervention group
Group type: COMPARATOR
Intervention: Typical BPPV (comparison group)
Number of subjects: 63
Study 16334720 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Liuwei Dihuang Wan (Bolus of the Six Drugs Including Rehmanniae)
Number of subjects: 100
Study 16334720 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone
Number of subjects: 100
Study 12871257 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported voice problems
Number of subjects: 204
Study 12871257 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert voice rating
Number of subjects: 204
Study 12871257 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective voice assessment (amplitude perturbation)
Number of subjects: 204
Study 9523308 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate solution 40 mg in 30 mL of water administered directly into the stomach, second part of the duodenum, or terminal ileum over 1 minute (study A)
Number of subjects: 8
Study 9523308 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate solution 40 mg in 30 mL of water administered directly into the second part of the duodenum over 1 minute and over 1 hour (study B)
Number of subjects: 8
Study 8595642 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily
Number of subjects: 9
Study 8595642 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 to 40 mg twice daily
Number of subjects: 9
Study 8595642 — intervention group
Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 9
Study 8595642 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 9
Study 2510372 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrient formula (Osmolite)
Number of subjects: 0
Study 2510372 — intervention group
Group type: COMPARATOR
Intervention: Food diet (F)
Number of subjects: 0
Study 2510372 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (ENF and F)
Number of subjects: 0
Study 785178 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin 75 or 100mg (1.4 mg/kg) single intramuscular injection
Number of subjects: 30
Study 785178 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin 50 or 75mg (1.9 or 2.1 mg/kg) b.i.d.
Number of subjects: 30
Study 785178 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin (both dosages)
Number of subjects: 30